A new peer-reviewed clinical trial conducted by researchers at Tel Aviv University and Reichman University found that ...

B7-33, a synthetic analog of relaxin-2, has emerged as a focal point in contemporary scientific research due to its selective ...

In many cultures, different eating and drinking rituals are followed. For the Japanese, their daily ritual is to drink ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally occurring particles called extracellular vesicles (EVs), they have created a ...

Teacher Retirement System of Texas grew its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 20.4% in the ...

Immunology is pivotal in addressing significant health challenges, from enhancing vaccine efficacy to identifying therapeutic targets for complex diseases.

Frankincense essential oil is known for its anti-inflammatory, antioxidant, and therapeutic properties. A recent study ...

Cytokinetics (CYTK) stock rises and rival Edgewise (EWTX) stock drops as the latter posts mixed Phase 2 trial data for its ...

Cytosorbents (NASDAQ:CTSO – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They presently have a ...

Regarding myeloma, Burke also shares his experience with myeloma BsAbs, saying, “I follow the drug label, administer the drug in the clinic, but then admit the patient directly to the hospital for ...

Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...

Cytokinetics, Incorporated’s CYTK share price has surged by 13.20%, which has investors questioning if this is right time to sell.